ASGR2
Basic information
Region (hg38): 17:7101322-7115700
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (43 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASGR2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001201352.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 39 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 39 | 3 | 2 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASGR2 | protein_coding | protein_coding | ENST00000380952 | 8 | 14379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.81e-10 | 0.0905 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.285 | 176 | 187 | 0.941 | 0.0000109 | 2065 |
Missense in Polyphen | 59 | 65.192 | 0.90502 | 810 | ||
Synonymous | 0.228 | 75 | 77.5 | 0.967 | 0.00000500 | 571 |
Loss of Function | 0.0601 | 14 | 14.2 | 0.983 | 6.09e-7 | 152 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000323 | 0.000309 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000171 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface.;
- Pathway
- Thyroid hormone synthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Asparagine N-linked glycosylation
(Consensus)
Intolerance Scores
- loftool
- 0.835
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.185
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.572
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asgr2
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- receptor-mediated endocytosis;cell surface receptor signaling pathway;viral process;protein N-linked glycosylation via asparagine;bone mineralization;regulation of protein stability;lipid homeostasis
- Cellular component
- plasma membrane;integral component of membrane;endoplasmic reticulum quality control compartment;perinuclear region of cytoplasm
- Molecular function
- asialoglycoprotein receptor activity;protein binding;carbohydrate binding